Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Do Antidepressants Induce Metabolic Syndromes METADAP Study

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliImekamilika
Wadhamini
Assistance Publique - Hôpitaux de Paris
Washirika
Institut National de la Santé Et de la Recherche Médicale, France

Maneno muhimu

Kikemikali

Since antidepressants and antipsychotics have common receptorial mechanisms of action (H1 antagonism, 5HT2 antagonism), the impact of antidepressants in terms of metabolic syndromes is a matter of concern.
The main objective of this study is to assess the differential impact of antidepressants in terms of weight gain and metabolic syndromes.

Maelezo

Since antidepressants and antipsychotics have common receptorial mechanisms of action (H1 antagonism, 5HT2 antagonism), the impact of antidepressants in terms of metabolic syndromes is a matter of concern.

The main objective of this study is to assess the differential impact of antidepressants in terms of weight gain and metabolic syndromes.

Prospective 6-month naturalistic cohort study, comparing 4 classes of antidepressants (SSRIs, SNRIs, TCAs and others) to a control group (ECT and r-TMS), in 600 patients with a major depressive disorder requiring the beginning of either antidepressant or ECT/r-TMS treatment.

Tarehe

Imethibitishwa Mwisho: 08/31/2007
Iliyowasilishwa Kwanza: 09/04/2007
Uandikishaji uliokadiriwa Uliwasilishwa: 09/06/2007
Iliyotumwa Kwanza: 09/09/2007
Sasisho la Mwisho Liliwasilishwa: 04/15/2014
Sasisho la Mwisho Lilichapishwa: 04/16/2014
Tarehe halisi ya kuanza kwa masomo: 10/31/2007
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 03/31/2013
Tarehe ya Kukamilisha Utafiti: 03/31/2013

Hali au ugonjwa

Major Depressive Disorder

Uingiliaji / matibabu

Drug: Tricyclic antidepressants

Awamu

-

Vikundi vya Arm

MkonoUingiliaji / matibabu
Experimental: A
antidepressant versus medical dispositive
Placebo Comparator: B

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 18 Years Kwa 18 Years
Jinsia Inastahiki KujifunzaAll
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- Age : 18-70

- Current major depressive episode (Major depressive disorder) based on the MINI interview

- HAM-D >18

- Requiring either antidepressant treatment, either ECT or r-TMS (as assessed by the clinician)

- Signed informed consent

Exclusion Criteria:

- Bipolar disorder (DSM-IV), Psychotic disorder (DSM-IV), Substance abuse or dependence (DSM-IV)

- Normothymic treatment

- Antipsychotic treatment

Matokeo

Hatua za Matokeo ya Msingi

1. Definition criteria of the metabolic syndromes: Weight and waist circumference Systolic and diastolic blood pressure Glycemia Triglyceridemia Cholesterolemia Insulinemia [at Months 0, 1, 3, 6]

Hatua za Matokeo ya Sekondari

1. Antidepressant efficacy (HAM-D, quickIDS-C, quickIDS-SR, CGI) [at Months 0, 1, 3, 6]

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge